The current European Association of Urology (EAU) guidelines propose using the neutrophil–lymphocyte ratio (NLR), albumin, C-reactive protein (CRP), De Ritis ratio, renal function and fibrinogen as prognostic indicators of tumor progression [2]. Here, CRP is linked to neoplasm.